Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,903 | -59,248 | -47,021 | -37,260 | -19,776 |
| Depreciation Amortization | 32 | 130 | 96 | 66 | 32 |
| Accounts payable and accrued liabilities | -1,213 | N/A | N/A | N/A | N/A |
| Other Working Capital | -1,421 | 2,460 | 1,893 | 2,912 | 2,827 |
| Other Operating Activity | 1,614 | 6,942 | 2,789 | 1,973 | 949 |
| Operating Cash Flow | $-7,891 | $-49,716 | $-42,242 | $-32,309 | $-15,968 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -212 | -212 | -200 | -175 |
| Net Acquisitions | N/A | -528 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-740 | $-212 | $-200 | $-175 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -201 | -1,034 | -722 | -410 | -102 |
| Common Stock Issued | 1,076 | -7 | 78 | 71 | 97 |
| Financing Cash Flow | $875 | $-1,041 | $-644 | $-340 | $-6 |
| Beginning Cash Position | 16,638 | 68,135 | 68,135 | 68,136 | 68,135 |
| End Cash Position | 9,622 | 16,638 | 25,037 | 35,288 | 51,986 |
| Net Cash Flow | $-7,016 | $-51,497 | $-43,098 | $-32,848 | $-16,149 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,891 | -49,716 | -42,242 | -32,309 | -15,968 |
| Capital Expenditure | N/A | -212 | -212 | -200 | -175 |
| Free Cash Flow | -7,891 | -49,928 | -42,454 | -32,509 | -16,143 |